Concepedia

Goldie Y.L. Lui

GY

Statistics

Publications

11

Citations

791

H-Index

11

Active since

2012

Affiliations

The University of Sydney(Current)

Fred Hutch Cancer Center

University of Washington

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

Centenary Institute

Goldie Y.L. Lui is an author at The University of Sydney specializing in molecular oncology, medicine, and oncology.

ORCID

Publications per year

2012–2021

11

Publications

11

The Iron-Regulated Metastasis Suppressor NDRG1 Targets NEDD4L, PTEN, and SMAD4 and Inhibits the PI3K and Ras Signaling Pathways

Žaklina Kovačević, Sherin Chikhani, Goldie Y.L. Lui et al. · Antioxidants and Redox Signaling · 2012 · 167 citations

, , +16

The Iron Chelator, Deferasirox, as a Novel Strategy for Cancer Treatment: Oral Activity Against Human Lung Tumor Xenografts and Molecular Mechanism of Action

Goldie Y.L. Lui, Peyman Obeidy, Samuel Ford et al. · Molecular Pharmacology · 2012 · 137 citations

, , +15

Dp44mT targets the AKT, TGF-β and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells

Kathleen A Dixon, Goldie Y.L. Lui, Žaklina Kovačević et al. · British Journal of Cancer · 2013 · 110 citations · Full text

, , +17

RAB27A promotes melanoma cell invasion and metastasis <i>via</i> regulation of pro‐invasive exosomes

Dajiang Guo, Goldie Y.L. Lui, Siew Li Lai et al. · International Journal of Cancer · 2018 · 100 citations

, , +17

Cell Cycle Phase-Specific Drug Resistance as an Escape Mechanism of Melanoma Cells

Kimberley A. Beaumont, David S. Hill, Sheena M. Daignault et al. · Journal of Investigative Dermatology · 2016 · 70 citations

, , +16

1–5 of 11